The Role of the Microbiome in the Development/Prevention of Food Allergies
The Role of the Microbiome in the Development/Prevention of Food Allergies
批准号:
7873387
负责人:
Gary B Huffnagle
金额:
$23.2万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-10 至 2012-08-31
关键词:
AdjuvantAdoptive TransferAllergensAllergicAnimal ModelAnimalsAntibioticsAntigensAutoantigensButyratesCD4 Positive T LymphocytesCandida albicansChickensCholera ToxinComplexDataDendritic CellsDevelopmentDietDiseaseDoseEnvironmentEnvironmental Risk FactorEpidemiologic StudiesFoodFood HypersensitivityGastrointestinal tract structureGenerationsHypersensitivityImmune ToleranceImmune responseImmune systemIncidenceIndigenousInflammatoryInflammatory ResponseLaboratoriesLactobacillusLamina PropriaMesenteryMusOralOrganismOvalbuminPlayPrevalencePreventionProbioticsProcessProteinsResearch PersonnelRoleSaponinSaponinsSignal TransductionSurfaceT cell responseTimeTretinoinYeastsallergic airway diseaseallergic responsecommensal microbescytokinefood allergengastrointestinallymph nodesmicrobiomemouse modeloral toleranceprebioticspreventpublic health relevanceresponse
中文摘要
描述(由申请人提供):在过去的几十年里,西方文化中食物过敏的患病率稳步上升。虽然过敏发生率增加的原因可能是多因素的,但越来越多的数据支持这样的假设,即胃肠道微生物群的组成可能是对其他无害的食物蛋白质产生过敏反应的一个促成因素。我们最近开发了一种对鸡卵清蛋白(OVA)食物过敏的小鼠模型,该模型是对微生物群扰动的反应。ag特异性T细胞反应将通过ova特异性初始DO11.10 CD4 T细胞的过继转移来追踪。我们的假设是,胃肠道微生物群的紊乱,包括酵母的暂时或长期生长,通过破坏调节网络和/或增强粘膜Th2反应的启动,促进了对高剂量食物过敏原暴露的Th2反应的启动。因此,针对微生物群(益生菌和益生元)的策略有可能恢复有缺陷的调节反应和/或防止过敏原启动。我们的目的是:1)确定口服OVA后微生物群破坏小鼠肠系膜淋巴结和固有层的细胞、体液和细胞因子反应;2)确定益生乳杆菌、益生元(scFOS)或两者联合使用对肠道菌群紊乱小鼠口服OVA后肠系膜淋巴结和固有层细胞、体液和细胞因子反应的影响;3)确定丁酸盐和全反式维甲酸对未处理和微生物群破坏小鼠MLN和LP分离的CD103-和CD103+树突状细胞活性的调节关系。
英文摘要
DESCRIPTION (provided by applicant): The prevalence of food allergies in Western cultures has steadily increased in the last several decades. While the cause of the increased incidence of allergies is likely to be multifactoral, a growing body of data supports the hypothesis that the composition of the gastrointestinal tract microbiota can be a contributing factor in the generation of allergic responses to otherwise innocuous food proteins. We have recently developed a mouse model of food allergy to chicken ovalbumin (OVA), which develops in response to microbiota perturbation. Ag-specific T cell responses will be tracked through the adoptive transfer of OVA-specific naive DO11.10 CD4 T-cells. Our hypothesis is that disturbances of the gastrointestinal microbiota, including the temporary or long-term outgrowth of yeast, promote the priming of a Th2 response to high dose food allergen exposure by disrupting regulatory networks and/or augmenting priming of mucosal Th2 responses. Therefore, strategies aimed at the microbiota (probiotics & prebiotcs) have the potential to restore defective regulatory responses and/or prevent allergen priming. Our aims are 1) to determine the cellular, humoral and cytokine responses in the mesenteric lymph nodes and lamina propria of microbiota-disrupted mice following oral delivery of OVA; 2) to determine the effect of a Lactobacillus probiotic, a prebiotic (scFOS) or the combination of the two on the cellular, humoral and cytokine responses in the mesenteric lymph nodes and lamina propria of microbiota-disrupted mice following oral delivery of OVA; 3) to determine the relationship between butyrate and all-trans retinoic acid on regulating the activity of CD103- and CD103+ dendritic cells isolated from the MLN and LP of untreated and microbiota-disrupted mice.
Public Health Relevance
Numerous epidemiologic studies have implicated disruptions of the indigenous microbiota (by antibiotics, diet, disease, or other environmental factors) as a causative factor in the development of mucosal inflammatory disorders, including food allergies. The data from this proposal will increase our understanding of the mechanisms connecting the indigenous microbiota and food allergies, including the mechanisms of probiosis to treat food allergies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neonatal RSV infection and alteration of allergic immune responses
-
批准号:10448373
-
项目类别:
-
资助金额:$44.81万
-
财政年份:2018
-
负责人:Gary B Huffnagle
-
依托单位:
Neonatal RSV infection and alteration of allergic immune responses
-
批准号:9763430
-
项目类别:
-
资助金额:$44.81万
-
财政年份:2018
-
负责人:Gary B Huffnagle
-
依托单位:
Neonatal RSV infection and alteration of allergic immune responses
-
批准号:10219079
-
项目类别:
-
资助金额:$44.81万
-
财政年份:2018
-
负责人:Gary B Huffnagle
-
依托单位:
Functional Analysis of the Pulmonary Microbiome during COPD
-
批准号:9542530
-
项目类别:
-
资助金额:$22.32万
-
财政年份:2017
-
负责人:Gary B Huffnagle
-
依托单位:
Pulmonary bacterial microbiome-epithelial cell interactions in COPD
-
批准号:8509021
-
项目类别:
-
资助金额:$36.94万
-
财政年份:2012
-
负责人:Gary B Huffnagle
-
依托单位:
Pulmonary bacterial microbiome-epithelial cell interactions in COPD
-
批准号:8337156
-
项目类别:
-
资助金额:$40.19万
-
财政年份:2012
-
负责人:Gary B Huffnagle
-
依托单位:
Pulmonary bacterial microbiome-epithelial cell interactions in COPD
-
批准号:8669148
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2012
-
负责人:Gary B Huffnagle
-
依托单位:
The Role of the Microbiome in the Development/Prevention of Food Allergies
-
批准号:8141254
-
项目类别:
-
资助金额:$19.24万
-
财政年份:2010
-
负责人:Gary B Huffnagle
-
依托单位:
The Interplay Between Host Immunity and Clostridium difficile Pathogenesis
-
批准号:8026744
-
项目类别:
-
资助金额:$44.17万
-
财政年份:2010
-
负责人:Gary B Huffnagle
-
依托单位:
Mucosal Mechanisms Linking Pulmonary and Gastrointestinal Inflammation/Immunity
-
批准号:7898627
-
项目类别:
-
资助金额:$18.88万
-
财政年份:2009
-
负责人:Gary B Huffnagle
-
依托单位:
Mucosal Mechanisms Linking Pulmonary and Gastrointestinal Inflammation/Immunity
-
批准号:7701050
-
项目类别:
-
资助金额:$22.32万
-
财政年份:2009
-
负责人:Gary B Huffnagle
-
依托单位:
Role of Fungal Microflora in Mucosal Tolerance/Immunity
-
批准号:7392833
-
项目类别:
-
资助金额:$35.11万
-
财政年份:2005
-
负责人:Gary B Huffnagle
-
依托单位:
Role of Fungal Microflora in Mucosal Tolerance/Immunity
-
批准号:7218573
-
项目类别:
-
资助金额:$35.79万
-
财政年份:2005
-
负责人:Gary B Huffnagle
-
依托单位:
Role of Fungal Microflora in Mucosal Tolerance/Immunity
-
批准号:6907647
-
项目类别:
-
资助金额:$37.74万
-
财政年份:2005
-
负责人:Gary B Huffnagle
-
依托单位:
Role of Fungal Microflora in Mucosal Tolerance/Immunity
-
批准号:7027625
-
项目类别:
-
资助金额:$36.85万
-
财政年份:2005
-
负责人:Gary B Huffnagle
-
依托单位:
Role of Fungal Microflora in Mucosal Tolerance/Immunity
-
批准号:7590336
-
项目类别:
-
资助金额:$35.11万
-
财政年份:2005
-
负责人:Gary B Huffnagle
-
依托单位:
Role of Oxylipins in Cryptococcal Pathogenesis
-
批准号:7012755
-
项目类别:
-
资助金额:$32.63万
-
财政年份:2004
-
负责人:Gary B Huffnagle
-
依托单位:
Role of Oxylipins in Cryptococcal Pathogenesis
-
批准号:7343260
-
项目类别:
-
资助金额:$31.01万
-
财政年份:2004
-
负责人:Gary B Huffnagle
-
依托单位:
Role of Oxylipins in Cryptococcal Pathogenesis
-
批准号:7172258
-
项目类别:
-
资助金额:$31.61万
-
财政年份:2004
-
负责人:Gary B Huffnagle
-
依托单位:
Role of Oxylipins in Cryptococcal Pathogenesis
-
批准号:6758954
-
项目类别:
-
资助金额:$37.08万
-
财政年份:2004
-
负责人:Gary B Huffnagle
-
依托单位:
海外基金